Accord Expands CNS Ambitions With Zubsolv Deal

Sets Launch Date For Opioid-Dependence Treatment In First Of 29 Markets

 
• By David Wallace
  
CNS Pills Bottle
The deal builds on Accord’s agreement with Molteni for Sixmo • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business